iDtheinvestordatabase
Home / Directory / Sofinnova
Active: new deal Oct 2025 Verified 4 Nov 2026

Sofinnova

Menlo Park, CA biopharmaceutical venture capital firm with about $2B in assets under management and committed capital, backing drug development companies.

Type
VC firm
Location
Menlo Park, California, United States
Backs
Biotech and pharma
Sectors
Biotech, Healthtech and life sciences
Fund size / AUM
$550M Sofinnova Venture Partners XII (Form D offering, 2024)
Latest fund or filing
22 Jun 2026
Portfolio mix
Biotech and pharma 100% (n=30, 1998 to 2026)

Fund filings (SEC Form D)

Latest fund on file
Sofinnova Venture Partners XII
Filed
22 Jun 2026 (amendment)
Fund size
$550M (total offering)
Fund vehicles filed in the last 12 months
1 (includes feeder and parallel vehicles)

See this fund's filings on SEC EDGAR

Contacts on file

For Sofinnova, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); how to pitch (the route the firm publishes); LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

Claris Biocitytxcoultreon.comexpeditiontx.com/mareatx

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 15 lists

Biotech investors in Silicon Valley (48)Biotech investors in the San Francisco Bay Area (88)Healthtech investors in Silicon Valley (91)Biotech investors in California (108)Healthtech investors in the San Francisco Bay Area (182)Healthtech investors in California (240)Biotech venture capital firms in the US (297)Venture capital firms in Silicon Valley (341)Biotech investors (484)Healthtech venture capital firms in the US (709)Venture capital firms in the San Francisco Bay Area (768)Venture capital firms in California (1,038)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Venture capital firms in the US (2,975)